Stocks and Investing Stocks and Investing
Thu, May 12, 2022
Wed, May 11, 2022

Madhu Kumar Maintained (ARCT) at Strong Sell with Decreased Target to $14 on, May 11th, 2022


Published on 2024-10-27 20:59:58 - WOPRAI, Madhu Kumar
  Print publication without navigation


Madhu Kumar of Goldman Sachs, Maintained "Arcturus Therapeutics Holdings Inc." (ARCT) at Strong Sell with Decreased Target from $16 to $14 on, May 11th, 2022.

Madhu has made no other calls on ARCT in the last 4 months.



There are 5 other peers that have a rating on ARCT. Out of the 5 peers that are also analyzing ARCT, 2 agree with Madhu's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Ed Arce of "HC Wainwright & Co." Maintained at Hold with Decreased Target to $19 on, Tuesday, May 10th, 2022
  • Steven Seedhouse of "Raymond James" Upgraded from Sell to Hold on, Monday, January 31st, 2022


These are the ratings of the 3 analyists that currently disagree with Madhu


  • Gena Wang of "Barclays" Maintained at Sell with Decreased Target to $17 on, Tuesday, May 10th, 2022
  • John Abbott of "Wells Fargo" Maintained at Buy with Decreased Target to $105 on, Friday, March 25th, 2022
  • Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Decreased Target to $86 on, Tuesday, March 15th, 2022